Intuitive evaluation of contemporary management strategies in thymoma—the largest Indian experience
RL Chowdhary, KS Chufal, M Ismail… - Reports of Practical …, 2023 - journals.viamedica.pl
Background: The aim was perusal of the treatment strategies, clinical outcomes and factors
impacting these outcomes in thymoma. Materials an dm ethods: A total of 119 patients …
impacting these outcomes in thymoma. Materials an dm ethods: A total of 119 patients …
Debulking surgery plus radiation: treatment choice for unresectable stage III thymic carcinoma
Y Zhai, Z Hui, Y Gao, J Liang, Z Zhou… - The Thoracic and …, 2020 - thieme-connect.com
Background Total resection may not be achieved in patients with thymic carcinoma,
particularly those with Masaoka stage III disease. Debulking surgery plus postoperative …
particularly those with Masaoka stage III disease. Debulking surgery plus postoperative …
Thymic Tissue Metabolomics and Bioengineering of an Artificial Thymic Carcinoma 3D Cell Culture for in vitro 3D/2D Drug Screening and the Investigation of Toxicity …
MIM AlWahsh - 2022 - archiv.ub.uni-heidelberg.de
Thymomas and thymic carcinomas (TC) are malignant thymic epithelial tumors (TETs) that
mostly lack targetable mutations. Metabolic signatures of TETs have not yet been studied …
mostly lack targetable mutations. Metabolic signatures of TETs have not yet been studied …